-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Leukemia is a group of heterogeneous blood diseases characterized by the uncontrolled and dysfunctional growth of white blood cells
Plants are an inexhaustible source of biologically active substances
Diabetes Digestion
Previous studies on animal models have shown that several compounds in the figure above have a wide range of cancer prevention and chemotherapy properties, and various approaches may be related to perfect synergy
prevention
In this study, 3 cell lines- human acute promyelocytic leukemia (HL60), human chronic myelogenous leukemia (K562) and normal Luo cells-were used to evaluate CSP polyphenol extracts:
Human acute promyelocytic leukemiaAs shown in the figure above, the extract can inhibit the spread of HL60 (IC50 = 11.
After K562 cell line was treated with 25μg/mL and HL60 cell line at 12μg/mL for 24 h, the number of viable cells was significantly reduced by 50%.
Within 14 days after CSP extract treatment, no signs of death or poisoning of experimental animals were found, and a single oral administration of 2000 mg/kg body weight of CSP extract did not interfere with the growth of mice
In this study, four receptors (ABL kinase, ABL1, BCL2, and FLT3) that are highly concerned in anti-leukemia research and treatment were selected as targets:
In this study, four receptors (ABL kinase, ABL1, BCL2, and FLT3) that are highly concerned in anti-leukemia research and treatment were selected as targets:The reference drug navitoclax has the highest affinity to the receptor (-11.
The drug navitoclax has the highest affinity to the receptor (-11.
In summary , this study shows that the anti-leukemia activity of CSP extract comes from the synergistic anti-cancer effect of catechin and rutin molecules
.
The anti-leukemia activity of
plant CSP extracts comes from the synergistic anti-cancer effect of catechin and rutin molecules .
Plant extracts have strong activity and fewer side effects, or can be used as a supplement or replacement for conventional treatment and chemotherapy
.
Leave a message here